Please note that only limited free access to this journal is available in your country or territory.

To access the full content of this article you must purchase it (US$9.49). After payment of this one-off fee, you will gain unrestricted online access to the article and a PDF version sent to your email.

As part of our special introductory offer, after purchasing this article you will have unrestricted access to all the articles in this issue for free!

Registered users can purchase/access the article by logging in below. To register for free click here

Registered users login here:

  • Email Address:
     
  • Password:
     
  •  
If you have forgotten your password click here
0 rating

Juvenile Dermatomyositis


Apaz MT, Saad-Magalhães C, Pistorio A et al.

Paediatric Rheumatology International Trials Organisation, Genoa, Italy.

 Arthritis Rheum 2009;61:509–17.

Editor’s note: Juvenile dermatomyositis (JDM) is a potentially debilitating childhood inflammatory myopathy that often requires high-dose immunosuppressive therapy to control its clinical manifestations. In this study, the authors aimed to describe changes in health related quality of life (HRQoL) in a large cohort of patients with active JDM within the Paediatric Rheumatology International Trials Organisation.

Please login or register to continue reading this article
Return to top
Login/Register

Post Page On

LATEST ARTICLES

Our most popular articles